MedPath
HSA Approval

BRITIL EYE DROPS, SUSPENSION 1% w/v

SIN17215P

BRITIL EYE DROPS, SUSPENSION 1% w/v

BRITIL EYE DROPS, SUSPENSION 1% w/v

April 8, 2025

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SUSPENSION, STERILE

OPHTHALMIC

Medical Information

S01EC04

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

WORLD MEDICINE İLAÇ SAN. VE TİC. A.Ş.

Active Ingredients

Brinzolamide

10.00mg/mL

Brinzolamide

Documents

Package Inserts

BRITIL Eyedrops PI.pdf

Approved: April 8, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.